Pregled bibliografske jedinice broj: 1136736
Should breast cancer patients be the focus of anti-smoking campaigns in transitional countries?
Should breast cancer patients be the focus of anti-smoking campaigns in transitional countries? // Abstracts for MASCC/ISOO Annual Meeting 2019
San Francisco (CA), Sjedinjene Američke Države: Springer Science+Business Media, 2019. str. 1-302 doi:10.1007/s00520-019-04813-1 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1136736 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Should breast cancer patients be the focus of anti-smoking campaigns in transitional countries?
Autori
Golčić, Marin ; Tomaš, Ilijan ; Stevanović, Aleksandra ; Golčić, Goran ; Dobrila-Dintinjana , Renata ; Cink Škalic, Mirjana ; Šambić Penc , Mirela ; Gović-Golčić, Lidija ; Baretić Marinac, Martina ; Belac Lovasić , Ingrid
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts for MASCC/ISOO Annual Meeting 2019
/ - : Springer Science+Business Media, 2019, 1-302
Skup
2019 MASCC/ISOO Annual Meeting
Mjesto i datum
San Francisco (CA), Sjedinjene Američke Države, 21.06.2019. - 23.06.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
karcinom dojke ; pušenje
(breast cancer ; smoking)
Sažetak
Introduction Studies have shown that breast cancer patients who smoke during cancer treatment, along with a higher symptom burden, exhibit a dramatically higher risk of death (HR 3.52). Majority of studies report that only 8-14% breast cancer survivors smoke, although recent research shows low smoking cessation in breast cancer patients in Western population after cancer diagnosis. Currently, although around 30% of females in Croatia are active smokers, no analysis regarding smoking cessation have been done. Methods The study was cross-sectional research in two clinical hospital centers in Croatia and involved 168 breast cancer patients undergoing active treatment, using a questionnaire. Results Breast cancer patients are relatively young (57.6±11.31 years) and rarely metastatic (22%). Only around a quarter of breast cancer patients smoked at the time of cancer diagnosis. However, 96% of breast cancer patients continue to smoke after a cancer diagnosis, although the percentage of patients who smoke over ten cigarettes a day dropped from 70% to 36%. However, these numbers are higher compared to other patients and are much higher than previously reported for the Western population. Conclusions Although breast cancer patients are expected to exhibit relatively long survival compared to other cancers, they are one of the patient groups least likely to engage in smoking cessation during the treatment, possibly due to low perceived risk. With new research emphasizing the dangers of smoking during cancer treatment, breast cancer patients should be one of the focus groups, especially in transitional countries with a high number of female smokers.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Osijek,
Klinički bolnički centar Rijeka,
Fakultet zdravstvenih studija u Rijeci
Profili:
Ingrid Belac-Lovasić
(autor)
Renata Dobrila-Dintinjana
(autor)
Aleksandra Stevanović
(autor)
Goran Golčić
(autor)
Ilijan Tomaš
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE